Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
Clinical trial NCT04283097 · COMPLETED
Trial details
- NCT number
- NCT04283097
- Sponsor
- Kangpu Biopharmaceuticals, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-13
- Primary completion
- 2024-12-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.